| Elizabeth Ann Jehle, CPNP-PC | |
|
375 Mount Pleasant Ave, West Orange, NJ 07052-2750 | |
| (973) 322-6900 | |
| (973) 926-2997 |
| Full Name | Elizabeth Ann Jehle |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Pediatrics |
| Location | 375 Mount Pleasant Ave, West Orange, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124553862 | NPI | - | NPPES |
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
InteKrin Therapeutics Inc. announced today it will present 6 month Phase 2b clinical data for edema in diabetic patients showing differentiation for INT131, a Selective PPAR-gamma Modulator (SPPARM), from Actos® pioglitazone, at the American Diabetes Association annual meeting in Orlando, FL, Monday, June 28, 2010 at 2:45 pm EDT during the "Update on BARI 2D -Treatment of Insulin Resistance" session.
Watson Pharmaceuticals, Inc. announced today that, under a settlement with Novartis Pharmaceuticals Corporation, Novartis Pharma AG, Novartis AG, Novartis International Pharmaceutical Ltd., and Proterra AG (collectively "Novartis"), Watson has commenced shipment of a generic version of Exelon® (rivastigmine tartrate) 1.5mg, 3mg, 4.5mg and 6mg capsules. Exelon® is used to treat dementia in people with Alzheimer's disease.
A text messaging program using mobile phone technology is being used in western Uganda to increase awareness of and knowledge about HIV/AIDS, IRIN/Plus News reports.
Today's headlines include reports about a new effort launched by the Obama administration and insurers to fight health care fraud.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of New Jersey denied Teva's motion to overturn an April 23, 2010, jury verdict finding the patent in suit not invalid. The Court also denied Wyeth and Nycomed's request for FDA to reset the date of Teva's final approval to January 2011, based on the fact that Teva has patent defenses remaining at the District Court, including patent misuse.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Ann Jehle, CPNP-PC 2212 April Dr, Martinsville, NJ 08836 Ph: (917) 364-1042 | Elizabeth Ann Jehle, CPNP-PC 375 Mount Pleasant Ave, West Orange, NJ 07052-2750 Ph: (973) 322-6900 |
News Archive
InteKrin Therapeutics Inc. announced today it will present 6 month Phase 2b clinical data for edema in diabetic patients showing differentiation for INT131, a Selective PPAR-gamma Modulator (SPPARM), from Actos® pioglitazone, at the American Diabetes Association annual meeting in Orlando, FL, Monday, June 28, 2010 at 2:45 pm EDT during the "Update on BARI 2D -Treatment of Insulin Resistance" session.
Watson Pharmaceuticals, Inc. announced today that, under a settlement with Novartis Pharmaceuticals Corporation, Novartis Pharma AG, Novartis AG, Novartis International Pharmaceutical Ltd., and Proterra AG (collectively "Novartis"), Watson has commenced shipment of a generic version of Exelon® (rivastigmine tartrate) 1.5mg, 3mg, 4.5mg and 6mg capsules. Exelon® is used to treat dementia in people with Alzheimer's disease.
A text messaging program using mobile phone technology is being used in western Uganda to increase awareness of and knowledge about HIV/AIDS, IRIN/Plus News reports.
Today's headlines include reports about a new effort launched by the Obama administration and insurers to fight health care fraud.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of New Jersey denied Teva's motion to overturn an April 23, 2010, jury verdict finding the patent in suit not invalid. The Court also denied Wyeth and Nycomed's request for FDA to reset the date of Teva's final approval to January 2011, based on the fact that Teva has patent defenses remaining at the District Court, including patent misuse.
› Verified 5 days ago
Yesica Cano, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 375 Mount Pleasant Ave, West Orange, NJ 07052 Phone: 973-731-9442 | |
Dr. Claude H. Rene-cunningham, DNP, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 105 Main St Apt 1a, West Orange, NJ 07052 Phone: 973-344-0300 | |
Rose Antony, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5 Brook End Dr, West Orange, NJ 07052 Phone: 973-324-3000 | |
Patricia Ann Shorrock, RN,APN,C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 101 Old Short Hills Rd, Suite 211, West Orange, NJ 07052 Phone: 973-736-4430 Fax: 973-736-3733 | |
Mr. Homero Paniagua, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1001 Pleasant Valley Way, West Orange, NJ 07052 Phone: 973-669-8448 Fax: 973-669-9536 | |
Corine Iwuala, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 97 Mayfair Dr, West Orange, NJ 07052 Phone: 973-866-5350 Fax: 973-381-1634 | |
Michele Colon, APN-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 347 Mount Pleasant Ave, Suite 205, West Orange, NJ 07052 Phone: 973-571-2121 |